|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
1994-4-28
|
|
pubmed:abstractText |
Lymphoma associated with Epstein-Barr virus (EBV) is a complication of bone marrow transplantation that responds poorly to standard forms of therapy. The lymphoma is usually of donor origin. We hypothesized that treatment with infusions of donor leukocytes, which contain cytotoxic T cells presensitized to EBV, might be an effective treatment.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
28
|
|
pubmed:volume |
330
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1185-91
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8093146-Adult,
pubmed-meshheading:8093146-Bone Marrow Transplantation,
pubmed-meshheading:8093146-Burkitt Lymphoma,
pubmed-meshheading:8093146-DNA, Viral,
pubmed-meshheading:8093146-Female,
pubmed-meshheading:8093146-Herpesviridae Infections,
pubmed-meshheading:8093146-Herpesvirus 4, Human,
pubmed-meshheading:8093146-Humans,
pubmed-meshheading:8093146-Leukemia,
pubmed-meshheading:8093146-Male,
pubmed-meshheading:8093146-Middle Aged,
pubmed-meshheading:8093146-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:8093146-Tissue Donors,
pubmed-meshheading:8093146-Tumor Virus Infections
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation.
|
|
pubmed:affiliation |
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Case Reports,
Research Support, Non-U.S. Gov't
|
